ORIGINAL RESEARCH—BASIC SCIENCE: Cyclic Nucleotide Signaling in Cavernous Smooth Muscle

Lin, 2003, Phosphodiesterases as therapeutic targets, Urology, 61, 685, 10.1016/S0090-4295(02)02439-1 Patel, 2001, Molecular biological approaches to unravel adenylyl cyclase signaling and function, Gene, 269, 13, 10.1016/S0378-1119(01)00448-6 Guimaraes, 2001, Vascular adrenoceptors: An update, Pharmacol Rev, 53, 319 Tabrizchi, 2001, Pharmacology of adenosine receptors in the vasculature, Pharmacol Ther, 91, 133, 10.1016/S0163-7258(01)00152-8 Takahashi, 1992, Effects of adenosine on canine penile erection, J Urol, 148, 1323, 10.1016/S0022-5347(17)36901-X Filippi, 2000, Functional adenosine receptors in human corpora cavernosa, Int J Androl, 23, 210, 10.1046/j.1365-2605.2000.00232.x Noto, 2001, Role of adenosine and P2 receptors in the penile tumescence in anesthetized dogs, Eur J Pharmacol, 425, 51, 10.1016/S0014-2999(01)01167-0 Conner, 2002, Interaction of calcitonin‐gene‐related peptide with its receptors, Biochem Soc Trans, 30, 451, 10.1042/bst0300451 Wimalawansa, 1992, Age‐related changes in tissue contents of immunoreactive calcitonin gene‐related peptide, Aging (Milano), 4, 211 Stief, 1991, Calcitonin‐gene‐related peptide: A possible role in human penile erection and its therapeutic application in impotent patients, J Urol, 146, 1010, 10.1016/S0022-5347(17)37989-2 Bivalacqua, 2001, Gene transfer of prepro‐calcitonin gene‐related peptide restores erectile function in the aged rat, Biol Reprod, 65, 1371, 10.1095/biolreprod65.5.1371 Nishimatsu, 2001, Effects of intracavernous administration of adrenomedullin on erectile function in rats, Peptides, 22, 1913, 10.1016/S0196-9781(01)00521-6 Narumiya, 2001, Genetic and pharmacological analysis of prostanoid receptor function, J Clin Invest, 108, 25, 10.1172/JCI200113455 Daley, 1996, Saenz de Tejada I. Prostanoid production in rabbit corpus cavernosum. II. Inhibition by oxidative stress, J Urol, 156, 1169, 10.1016/S0022-5347(01)65744-6 Moreland, 2001, O2‐dependent prostanoid synthesis activates functional PGE receptors on corpus cavernosum smooth muscle, Am J Physiol Heart Circ Physiol, 281, 552, 10.1152/ajpheart.2001.281.2.H552 Hedlund, 1985, Comparison of the responses to drugs acting on adrenoreceptors and muscarinic receptors in human isolated corpus cavernosum and cavernous artery, J Auton Pharmacol, 5, 81, 10.1111/j.1474-8673.1985.tb00568.x Bosch, 1989, Changes in penile hemodynamics after intra cavernous injection of PGE1 and prostaglandin I2 in pig‐tailed monkeys, Int J Impot Res, 1, 211 Angulo, 2002, Regulation of human penile smooth muscle tone by prostanoid receptors, Br J Pharmacol, 136, 23, 10.1038/sj.bjp.0704675 Moreland, 2003, Functional prostaglandin E (EP) receptors in human penile corpus cavernosum, Int J Impot Res, 15, 362, 10.1038/sj.ijir.3901042 Porst, 1996, The rationale for prostaglandin E1 in erectile failure: A survey of worldwide experience, J Urol, 155, 802, 10.1016/S0022-5347(01)66315-8 Andersson, 2001, Neurophysiology/pharmacology of erection, Int J Impot Res, 13, 8, 10.1038/sj.ijir.3900718 Guidone, 2002, Characterization of VIP and PACAP receptors in cultured rat penis corpus cavernosum smooth muscle cells and their interaction with guanylate cyclase‐B receptors, Regul Pept, 108, 63, 10.1016/S0167-0115(02)00107-6 Juenemann, 1987, The role of vasoactive intestinal polypeptide as a neurotransmitter in canine penile erection: A combined in vivo and immunohistochemical study, J Urol, 138, 871, 10.1016/S0022-5347(17)43406-9 Kiely, 1989, Penile response to intracavernosal vasoactive intestinal polypeptide alone and in combination with other vasoactive agents, Br J Urol, 64, 191, 10.1111/j.1464-410X.1989.tb05986.x Pickard, 1993, Evidence against vasoactive intestinal polypeptide as the relaxant neurotransmitter in human cavernosal smooth muscle, Br J Pharmacol, 108, 497, 10.1111/j.1476-5381.1993.tb12831.x Palmer, 1994, Characterization of cyclic AMP accumulation in cultured human corpus cavernosum smooth muscle cells, J Urol, 152, 1308, 10.1016/S0022-5347(17)32573-9 Shen, 2000, Effects of androgen and ageing on gene expression of vasoactive intestinal polypeptide in rat corpus cavernosum, BJU Int, 86, 133, 10.1046/j.1464-410x.2000.00721.x Sullivan, 1998, Differential alterations of prostacyclin, cyclic AMP and cyclic GMP formation in the corpus cavernosum of the diabetic rabbit, Br J Urol, 82, 578, 10.1046/j.1464-410X.1998.00768.x Johnson, 2001, Dynamics of cAMP‐dependent protein kinase, Chem Rev, 101, 2243, 10.1021/cr000226k Shabb, 2001, Physiological substrates of cAMP‐dependent protein kinase, Chem Rev, 101, 2381, 10.1021/cr000236l Liu, 1999, J Biol Chem, 274, 10557, 10.1074/jbc.274.15.10557 Conti, 2000, Phosphodiesterases and cyclic nucleotide signaling in endocrine cells, Mol Endocrinol, 14, 1317, 10.1210/mend.14.9.0534 Funakoshi, 2002, Critical role of cAMP‐response element‐binding protein for angiotensin II‐induced hypertrophy of vascular smooth muscle cells, J Biol Chem, 277, 18710, 10.1074/jbc.M110430200 Quinn, 2004, Multisite phosphorylation mechanism for protein kinase A activation of the smooth muscle ATP‐sensitive K+ channel, Circ Res, 94, 1359, 10.1161/01.RES.0000128513.34817.c4 Insuk, 2003, Molecular basis and characteristics of KATP channel in human corporal smooth muscle cells, Int J Impot Res, 15, 258, 10.1038/sj.ijir.3901013 Matsuo, 2001, Discovery of a natriuretic peptide family and their clinical application, Can J Physiol Pharmacol, 79, 736, 10.1139/y01-054 Potter, 2001, Guanylyl cyclase‐linked natriuretic peptide receptors: Structure and regulation, J Biol Chem, 276, 6057, 10.1074/jbc.R000033200 Chauhan, 2003, Release of C‐type natriuretic peptide accounts for the biological activity of endothelium‐derived hyperpolarizing factor, Proc Natl Acad Sci USA, 100, 1426, 10.1073/pnas.0336365100 Kim, 1998, Presence and biological activity of C‐type natriuretic peptide‐dependent guanylate cyclase‐coupled receptor in the penile corpus cavernosum, J Urol, 159, 1741, 10.1097/00005392-199805000-00104 Kuthe, 2003, Expression of guanylyl cyclase B in the human corpus cavernosum penis and the possible involvement of its ligand C‐type natriuretic polypeptide in the induction of penile erection, J Urol, 169, 1918, 10.1097/01.ju.0000055602.35858.8f Hurt, 2002, Akt‐dependent phosphorylation of endothelial nitric‐oxide synthase mediates penile erection, Proc Natl Acad Sci USA, 99, 4061, 10.1073/pnas.052712499 Carrier, 1997, Nitrovasodilators relax mesenteric microvessels by cGMP‐induced stimulation of Ca‐activated K channels, Am J Physiol, 273, 76 Cartledge, 2001, The role of nitric oxide in penile erection, Expert Opin Pharmacother, 2, 95, 10.1517/14656566.2.1.95 Haas, 1998, Erectile dysfunction in aging: Upregulation of endothelial nitric oxide synthase, Urology, 51, 516, 10.1016/S0090-4295(97)00715-2 Bakircioglu, 2001, Decreased trabecular smooth muscle and caveolin‐1 expression in the penile tissue of aged rats, J Urol, 166, 734, 10.1016/S0022-5347(05)66052-1 Rajasekaran, 2002, Altered growth factor expression in the aging penis: The Brown‐Norway rat model, J Androl, 23, 393 Champion, 1999, Gene transfer of endothelial nitric oxide synthase to the penis augments erectile responses in the aged rat, Proc Natl Acad Sci USA, 96, 11648, 10.1073/pnas.96.20.11648 Magee, 2002, Gene therapy of erectile dysfunction in the rat with penile neuronal nitric oxide synthase, Biol Reprod, 67, 20, 10.1093/biolreprod/67.1.20 Chancellor, 2003, Nitric oxide synthase gene transfer for erectile dysfunction in a rat model, BJU Int, 91, 691, 10.1046/j.1464-410X.2003.04219.x Burnett, 1996, Nitric oxide‐dependent penile erection in mice lacking neuronal nitric oxide synthase, Mol Med, 2, 288, 10.1007/BF03401627 Burnett, 2002, Noncholinergic penile erection in mice lacking the gene for endothelial nitric oxide synthase, J Androl, 23, 92, 10.1002/j.1939-4640.2002.tb02601.x Andreopoulos, 2000, Molecular aspects of soluble guanylyl cyclase regulation, General Pharmacol, 34, 147, 10.1016/S0306-3623(00)00062-8 Behrends, 2000, Expression of nitric oxide‐sensitive guanylyl cyclase subunits in human corpus cavernosum, Biochem Pharmacol, 59, 713, 10.1016/S0006-2952(99)00381-0 Mizusawa, 2002, Nitric oxide independent activation of guanylate cyclase by YC‐1 causes erectile responses in the rat, J Urol, 167, 2276, 10.1016/S0022-5347(05)65142-7 Klotz, 2000, Soluble guanylate cyclase and cGMP‐dependent protein kinase I expression in the human corpus cavernosum, Int J Impot Res, 12, 157, 10.1038/sj.ijir.3900524 Boerth, 1994, Expression of the catalytic domain of cyclic GMP‐dependent protein kinase in a baculovirus system, FEBS Lett, 342, 255, 10.1016/0014-5793(94)80512-1 Collins, 1999, Cyclic AMP‐ and cyclic GMP‐dependent protein kinases differ in their regulation of cyclic AMP response element‐dependent gene transcription, J Biol Chem, 274, 8391, 10.1074/jbc.274.13.8391 Feil, 2002, Functional reconstitution of vascular smooth muscle cells with cGMP‐dependent protein kinase I isoforms, Circ Res, 90, 1080, 10.1161/01.RES.0000019586.95768.40 Hedlund, 2000, Erectile dysfunction in cyclic GMP‐dependent kinase I‐deficient mice, Proc Natl Acad Sci USA, 97, 2349, 10.1073/pnas.030419997 Tegge, 1995, Determination of cyclic nucleotide‐dependent protein kinase substrate specificity by the use of peptide libraries on cellulose paper, Biochemistry, 34, 10569, 10.1021/bi00033a032 Murthy, 2003, Selective phosphorylation of the IP3R‐I in vivo by cGMP‐dependent protein kinase in smooth muscle, Am J Physiol Gastrointest Liver Physiol, 284, 221, 10.1152/ajpgi.00401.2002 Krall, 1988, Characterization of cyclic nucleotide and inositol 1,4,5‐trisphosphate‐sensitive calcium‐exchange activity of smooth muscle cells cultured from the human corpora cavernosa, Biol Reprod, 39, 913, 10.1095/biolreprod39.4.913 Schlossmann, 2000, Regulation of intracellular calcium by a signalling complex of IRAG, IP3 receptor and cGMP kinase Ibeta, Nature, 404, 197, 10.1038/35004606 Lalli, 1999, [Ca2+]i homeostasis and cyclic nucleotide relaxation in aorta of phospholamban‐deficient mice, Am J Physiol, 277, 963 Schubert, 2001, Protein kinases: Tuners of the BKCa channel in smooth muscle, Trends Pharmacol Sci, 22, 505, 10.1016/S0165-6147(00)01775-2 Lee, 2001, Effects of nitric oxide on the Ca2+‐activated potassium channels in smooth muscle cells of the human corpus cavernosum, Urol Res, 29, 359, 10.1007/s002400100211 Malysz, 2001, Potassium outward currents in freshly dissociated rabbit corpus cavernosum myocytes, J Urol, 166, 1167, 10.1016/S0022-5347(05)65940-X Archer, 2002, Potassium channels and erectile dysfunction, Vascul Pharmacol, 38, 61, 10.1016/S1537-1891(02)00127-1 Christ, 2004, Intracorporal injection of hSlo cDNA restores erectile capacity in STZ‐diabetic F‐344 rats in vivo, Am J Physiol Heart Circ Physiol, 287, 1544, 10.1152/ajpheart.00792.2003 Mullershausen, 2001, Rapid nitric oxide‐induced desensitization of the cGMP response is caused by increased activity of phosphodiesterase type 5 paralleled by phosphorylation of the enzyme, J Cell Biol, 155, 271, 10.1083/jcb.200107001 Woodrum, 2003, Phosphorylation  of  the  heat shock‐related protein, HSP20, mediates cyclic nucleotide‐dependent relaxation, J Vasc Surg, 37, 874, 10.1067/mva.2003.153 Surks, 1999, Regulation of myosin phosphatase by a specific interaction with cGMP‐dependent protein kinase Ialpha, Science, 286, 1583, 10.1126/science.286.5444.1583 Huang, 2004, Unzipping the role of myosin light chain phosphatase in smooth muscle cell relaxation, J Biol Chem, 279, 597, 10.1074/jbc.M308496200 Tokui, 1996, Enhancement of smooth muscle contraction with protein phosphatase inhibitor 1: Activation of inhibitor 1 by cGMP‐dependent protein kinase, Biochem Biophys Res Commun, 220, 777, 10.1006/bbrc.1996.0480 Carr, 2001, Is myosin phosphatase regulated in vivo by inhibitor‐1? Evidence from inhibitor‐1 knockout mice, J Physiol, 534, 357, 10.1111/j.1469-7793.2001.00357.x Sauzeau, 2000, Cyclic GMP‐dependent protein kinase signaling pathway inhibits RhoA‐induced Ca2+ sensitization of contraction in vascular smooth muscle, J Biol Chem, 275, 21722, 10.1074/jbc.M000753200 Jiang, 1992, Direct evidence for cross‐activation of cGMP‐dependent protein kinase by cAMP in pig coronary arteries, J Biol Chem, 267, 1015, 10.1016/S0021-9258(18)48388-3 Eckly‐Michel, 1997, Involvement of cyclic nucleotide‐dependent protein kinases in cyclic AMP‐mediated vasorelaxation, Br J Pharmacol, 122, 158, 10.1038/sj.bjp.0701339 Dhanakoti, 2000, Involvement of cGMP‐dependent protein kinase in the relaxation of ovine pulmonary arteries to cGMP and cAMP, J Appl Physiol, 88, 1637, 10.1152/jappl.2000.88.5.1637 Wang, 1999, Possible obligatory functions of cyclic nucleotides in hypercapnia‐induced cerebral vasodilation in adult rats, Am J Physiol, 276, 480 White, 2000, cAMP‐dependent vasodilators cross‐activate the cGMP‐dependent protein kinase to stimulate BK (Ca) channel activity in coronary artery smooth muscle cells, Circ Res, 86, 897, 10.1161/01.RES.86.8.897 Barman, 2003, cAMP activates BKCa channels in pulmonary arterial smooth muscle via cGMP‐dependent protein kinase, Am J Physiol Lung Cell Mol Physiol, 284, 1004, 10.1152/ajplung.00295.2002 Lin, 2001, Age‐related decrease of protein kinase G activation in vascular smooth muscle cells, Biochem Biophys Res Commun, 287, 244, 10.1006/bbrc.2001.5567 Lin, 2002, Cyclic AMP and cyclic GMP activate protein kinase G in cavernosal smooth muscle cells: Old age is a negative factor, BJU Int, 89, 576, 10.1046/j.1464-410X.2002.02643.x Lincoln, 1990, cGMP‐dependent protein kinase mediates the reduction of Ca2+ by cAMP in vascular smooth muscle cells, Am J Physiol, 258, 399, 10.1152/ajpcell.1990.258.3.C399 Lincoln, 1995, cGMP signaling through cAMP‐ and cGMP‐dependent protein kinases, Adv Pharmacol, 34, 305, 10.1016/S1054-3589(08)61094-7 Pfeifer, 1998, Defective smooth muscle regulation in cGMP kinase I‐deficient mice, EMBO J, 17, 3045, 10.1093/emboj/17.11.3045 Sausbier, 2000, Mechanisms of NO/cGMP‐dependent vasorelaxation, Circ Res, 87, 825, 10.1161/01.RES.87.9.825 Francis, 2001, Cyclic nucleotide phosphodiesterases: Relating structure and function, Prog Nucleic Acid Res Mol Biol, 65, 1 Corbin, 2000, Phosphorylation of phosphodiesterase‐5 by cyclic nucleotide‐dependent protein kinase alters its catalytic and allosteric cGMP‐binding activities, Eur J Biochem, 267, 2760, 10.1046/j.1432-1327.2000.01297.x Lin, 2001, Identification and regulation of human PDE5A gene promoter, Biochem Biophys Res Commun, 280, 684, 10.1006/bbrc.2000.4220 Lin, 2001, Regulation of human PDE5A2 intronic promoter by cAMP and cGMP: Identification of a critical Sp1‐binding site, Biochem Biophys Res Commun, 280, 693, 10.1006/bbrc.2000.4221 Montorsi, 2004, Review of phosphodiesterases in the urogenital system: New directions for therapeutic intervention, J Sex Med, 1, 322, 10.1111/j.1743-6109.04047.x Küthe, 2001, Expression of different phosphodiesterase genes in human cavernous smooth muscle, J Urol, 165, 280, 10.1097/00005392-200101000-00079 Eardley, 2002, Tadalafil (Cialis) for men with erectile dysfunction, Int J Clin Pract, 56, 300 Kuthe, 2002, Phosphodiesterase inhibitors for the treatment of erectile dysfunction, Curr Opin Investig Drugs, 3, 1489 Stief, 2000, Effects of sildenafil on cAMP and cGMP levels in isolated human cavernous and cardiac tissue, Urology, 55, 146, 10.1016/S0090-4295(99)00371-4 Uckert, 2004, Interactions between cGMP‐ and cAMP‐pathways are involved in the regulation of penile smooth muscle tone, World J Urol, 22, 261, 10.1007/s00345-003-0394-4 Kim, 2000, Cross‐regulation of intracellular cGMP and cAMP in cultured human corpus cavernosum smooth muscle cells, Mol Cell Biol Res Commun, 4, 10, 10.1006/mcbr.2000.0249 Zhong, 1999, Alpha1‐adrenoceptor subtypes, Eur J Pharmacol, 375, 261, 10.1016/S0014-2999(99)00222-8 Hayabuchi, 2001, Evidence for involvement of A‐kinase anchoring protein in activation of rat arterial K (ATP) channels by protein kinase A, J Physiol, 536, 421, 10.1111/j.1469-7793.2001.0421c.xd Vo, 1998, Identification of cGMP‐dependent protein kinase anchoring proteins (GKAPs), Biochem Biophys Res Commun, 246, 831, 10.1006/bbrc.1998.8722 Yuasa, 2000, Binding and phosphorylation of a novel male germ cell‐specific cGMP‐dependent protein kinase‐anchoring protein by cGMP‐dependent protein kinase Ialpha, J Biol Chem, 275, 4897, 10.1074/jbc.275.7.4897 Matsuzaki, 2002, Aquaporins: A water channel family, Anat Sci Int, 77, 85, 10.1046/j.0022-7722.2002.00020.x Chin, 2002, Reinventing the wheel of cyclic AMP: Novel mechanisms of cAMP signaling, Ann NY Acad Sci, 968, 49, 10.1111/j.1749-6632.2002.tb04326.x Mills, 2001, Vasoconstrictors in erectile physiology, Int J Impot Res, 13, 29, 10.1038/sj.ijir.3900774 Qiao, 2003, PKA inhibits RhoA activation: A protection mechanism against endothelial barrier dysfunction, Am J Physiol Lung Cell Mol Physiol, 284, 972, 10.1152/ajplung.00429.2002 Bolz, 2003, Nitric oxide‐induced decrease in calcium sensitivity of resistance arteries is attributable to activation of the myosin light chain phosphatase and antagonized by the RhoA/Rho‐kinase pathway, Circulation, 107, 3081, 10.1161/01.CIR.0000074202.19612.8C